RSA Viewpoints
9th Annual European Life Science CEO Forum: the Impact on Talent: Advice to Clients
The ‘Davos’ of Life Sciences has been and gone for another year and the formal discussions focused on the evolving finance and M&A market,...
Future Talent Hard Data and Soft Skills
Imagine 1000 HR professionals in a theatre. Everyone with work and people challenges, mobile phones and email to answer. Cue Martine Wright, a survivor...
New thinkers needed – pharma supply chain management has entered a new world
Once seen as a less glamorous area of the pharma industry, supply chain management (SCM) is fast gaining a much higher profile. The talent...
Let’s face facts: it’s a candidate market for senior talent across life sciences
Tens of thousands of pharma jobs have been lost in recent years. So can smaller companies now select at leisure from an overflowing pool...
Biotech & Money, London, 2016
The meeting focused on harnessing the value of innovation and new models for collaboration. No small task. It had a strong UK focus but...
What Makes Successful Biotech Boards?
This report looks forensically at correlations between company performance and Board composition. From this we draw out lessons that can be learned from the...
New study looks at the impact of boards on biotech company performance
UK companies performing less well than those in mainland Europe RSA has published the latest of its Talent Equity® reports, an analysis of biotech company...
Report from JP Morgan 2016
The ‘Salmon Run’ of the Life Sciences is over for another year. Here are some take home messages. Public funding is uncertain but institutional investor coffers are full The withdrawal...
Talent equity is the long term value of biotech
Valuation of IP is familiar to every investor in the biotech sector and careful due diligence is essential before putting money at risk. We...
RSA’s Chris Molloy and Nick Stephens speaking at the Pharma Integrates Conferences – November 2015
Chris Molloy talks about the future of ‘big data’ in Pharma (INSERT VIDEO) Nick Stephens on ‘The people ingredient: mapping Pharma’s future’ (INSERT...
Talent: the key to biotech value creation
Everyone’s happy to talk about how important talent is to tech and life sciences companies but when it comes to valuation the financial community...
Avoid firing through better hiring
Luke Johnson, the serial entrepreneur and investor made a critical insight in his recent column in the Sunday Times. He wrote about how difficult and costly it...
Specialised Skills and Total Focus Driving Orphan Growth
By Chris Molloy, CEO of RSA, the world’s largest Talent Consultancy dedicated to the Life Sciences industry. It’s easy to be patient-focused when you’re...
Due diligence needed in exec hiring: the difference between success and failure
We recently showed the cost of making bad senior hires, with 48% going wrong in the first 18 months. To remind you of the enormity of...
Hiring new talent – it pays to be diligent
Companies hire new senior talent to fuel corporate success. Too often it proves to be an expensive failure. New data from Leadership IQ1 across...
Transformational leadership for Singapore health initiative
Investment in oral health The 23rd September 2015 saw the ground breaking for a new Institute of Oral Health in Singapore. We believe that this...